Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Popovsky Mark A

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Popovsky Mark A since year 2005. The trader's CIK number is 1325505. At the time of this reporting, Popovsky Mark A is the VP, Corporate Medical Director of Haemonetics Corp . (stock ticker symbol HAE). See this page for all insider trading activities at Haemonetics Corp .

Stock purchases, sales, and option exercises reported by insider Popovsky Mark A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-05-01 HAE Haemonetics Corp Purchase 246 44.35 10,910
2008-01-02 HAE Haemonetics Corp Option Exercise 10,000 28.88 288,825
2008-01-02 HAE Haemonetics Corp Sale 10,000 61.98 619,800
2007-11-01 HAE Haemonetics Corp Purchase 253 40.66 10,287
2007-07-02 HAE Haemonetics Corp Option Exercise 7,000 22.72 159,031
2007-07-02 HAE Haemonetics Corp Sale 7,000 52.79 369,504
2007-05-01 HAE Haemonetics Corp Purchase 282 38.63 10,894
2007-04-25 HAE Haemonetics Corp Option Exercise 7,000 22.72 159,031
2007-04-25 HAE Haemonetics Corp Sale 7,000 48.00 336,000
2007-02-02 HAE Haemonetics Corp Option Exercise 10,000 22.72 227,188
2007-02-02 HAE Haemonetics Corp Sale 10,000 47.79 477,900
2006-11-01 HAE Haemonetics Corp Purchase 228 38.76 8,837
2006-05-01 HAE Haemonetics Corp Purchase 258 41.52 10,712
2006-02-02 HAE Haemonetics Corp Option Exercise 7,000 22.72 159,033
2006-02-02 HAE Haemonetics Corp Sale 7,000 50.20 351,400
2005-05-02 HAE Haemonetics Corp Purchase 441 27.20 11,995

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Popovsky Mark A (VP, Corporate Medical Director of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.